Clinical Trial Update: Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a slow-release pacifier delivering the probiotic Bifidobacterium lactis BB-12 and xylitol for dental caries and related infe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Caries
• Infectious Diseases

Drugs mentioned

• Bifidobacterium lactis BB-12 (Bifidobacterium lactis BB-12)
• Xylitol (xylitol)

Snippet

Sponsor: University of Turku | Conditions: Dental Caries, Infectious Diseases | Phase 4 | Status: COMPLETED